MA
REGN icon

Mutual Advisors’s Regeneron Pharmaceuticals REGN Stock Holding History

Mutual Advisors’s Portfolio REGN Stock Details REGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$356K Sell
461
-41
-8% -$31.4K 0.01% 1049
2025
Q4 		$388K Sell
502
-26
-5% -$17.7K 0.01% 993
2025
Q3 		$304K Sell
528
-360
-41% -$204K 0.01% 1047
2025
Q2 		$500K Buy
888
+50
+6% +$27.9K 0.01% 778
2025
Q1 		$505K Sell
838
-137
-14% -$94.2K 0.01% 707
2024
Q4 		$676K Sell
975
-200
-17% -$168K 0.02% 604
2024
Q3 		$1.09M Buy
1,175
+212
+22% +$236K 0.03% 454
2024
Q2 		$1.04M Buy
963
+7
+0.7% +$6.79K 0.03% 479
2024
Q1 		$920K Sell
956
-739
-44% -$703K 0.03% 497
2023
Q4 		$1.49M Sell
1,695
-359
-17% -$296K 0.05% 336
2023
Q3 		$1.69M Buy
2,054
+1,242
+153% +$976K 0.07% 288
2023
Q2 		$583K Sell
812
-52
-6% -$40.1K 0.02% 590
2023
Q1 		$710K Buy
864
+68
+9% +$51.3K 0.03% 523
2022
Q4 		$574K Buy
796
+3
+0.4% +$2.21K 0.03% 549
2022
Q3 		$546K Buy
793
+82
+12% +$51.6K 0.03% 535
2022
Q2 		$420K Buy
711
+20
+3% +$13K 0.03% 591
2022
Q1 		$483K Buy
691
+7
+1% +$4.43K 0.03% 581
2021
Q4 		$432K Buy
684
+46
+7% +$28.3K 0.02% 621
2021
Q3 		$386K Sell
638
-25
-4% -$15.5K 0.02% 632
2021
Q2 		$370K Buy
+663
New +$336K 0.02% 624
2020
Q3 		– Sell
-1,125
Closed -$702K – 698
2020
Q2 		$702K Buy
+1,125
New +$639K 0.07% 292

Other funds holding REGN

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return

Mutual Advisors's REGN Position: Q1 2026 in Review

Mutual Advisors reduced its Regeneron Pharmaceuticals (REGN) stake by 8.2% in Q1 2026, selling an estimated $31.4K and leaving 461 shares worth $356K. The position accounts for 0.01% of the portfolio, ranked #1049.

Mutual Advisors first reported a position in REGN in Q2 2020 and has held it in 21 quarters since. The position peaked at $1.69M in Q3 2023. 1,392 funds tracked by Wall St. Rank hold REGN as of Q1 2026.

  • Mutual Advisors held 461 shares of Regeneron Pharmaceuticals worth $356K as of Q1 2026.
  • Mutual Advisors sold 41 Regeneron Pharmaceuticals shares in Q1 2026, an estimated $31.4K.
  • Regeneron Pharmaceuticals made up 0.01% of Mutual Advisors's portfolio in Q1 2026, its #1049 holding.
  • Mutual Advisors first reported a position in Regeneron Pharmaceuticals in Q2 2020 and has held it in 21 quarters since.
  • Mutual Advisors's Regeneron Pharmaceuticals position peaked at $1.69M in Q3 2023.
  • 1,392 funds tracked by Wall St. Rank held Regeneron Pharmaceuticals as of Q1 2026.

Based on Mutual Advisors's 13F filing for Q1 2026, filed 4 May 2026.